×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RDY – dr. reddy's laboratories ltd (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RDY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
08:00 am
rdy
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
Low
Report
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
11/18
09:51 am
rdy
ValGenesis Wraps Up Global ValConnect Innovation Day Series with Hyderabad Event [Yahoo! Finance]
Low
Report
ValGenesis Wraps Up Global ValConnect Innovation Day Series with Hyderabad Event [Yahoo! Finance]
10/24
06:59 pm
rdy
Dr. Reddy's Laboratories Limited (RDY) Q2 2026 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Dr. Reddy's Laboratories Limited (RDY) Q2 2026 Earnings Call Transcript [Seeking Alpha]
10/24
12:21 pm
rdy
Dr. Reddy's Laboratories (NYSE:RDY) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Dr. Reddy's Laboratories (NYSE:RDY) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
10/22
12:00 pm
rdy
Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025
Low
Report
Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025
10/13
09:35 am
rdy
Lords Mark Industries Ltd. secures US FDA Registration, Reinforces India's Position in Global Healthcare Manufacturing [Yahoo! Finance]
Low
Report
Lords Mark Industries Ltd. secures US FDA Registration, Reinforces India's Position in Global Healthcare Manufacturing [Yahoo! Finance]
10/8
12:19 pm
rdy
Dr. Reddy's Laboratories (NYSE:RDY) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Dr. Reddy's Laboratories (NYSE:RDY) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
10/6
11:50 am
rdy
ESPR Settles Nexletol/Nexlizet Patent Litigation With RDY, Stock Up [Yahoo! Finance]
Low
Report
ESPR Settles Nexletol/Nexlizet Patent Litigation With RDY, Stock Up [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
7/24/2025
04:01 pm
RDY
dr. reddy's laboratories ltd
BEAT
Report
0.4%
dr. reddy's laboratories ltd
7/23/2025
04:05 pm
RDY
dr. reddy's laboratories ltd
BEAT
Report
0.8%
dr. reddy's laboratories ltd
7/23/2025
08:02 am
RDY
dr. reddy's laboratories ltd
BEAT
Report
-0.4%
dr. reddy's laboratories ltd
5/12/2025
04:04 pm
RDY
dr. reddy's laboratories ltd
BEAT
Report
1.2%
dr. reddy's laboratories ltd
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
09:55 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Dec 02
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Dec 02
11/28
08:52 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 28
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 28
11/28
06:03 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 24
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 24
11/28
06:03 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 24
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 24
11/25
06:04 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 24
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 24
11/18
10:34 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 18
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 18
11/17
11:57 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 17
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 17
11/17
06:09 am
rdy
Form 6-K DR REDDYS LABORATORIES For: Nov 14
Low
Report
Form 6-K DR REDDYS LABORATORIES For: Nov 14
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Dr.Reddy's Laboratories Ltd (NYSE: RDY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.
6.2%
1/27 Form 6-K DR REDDYS LABORATORIES For: Jan 27 5.3%
4/9 Form SC 13G/A DR REDDYS LABORATORIES Filed by: BlackRock Inc. 4.8%
3/20 Dr. Reddy's launches pyrimethamine tablets in U.S. [Seeking Alpha] 3.9%
3/17 Dr. Reddy's Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market 3.0%
10/23 Dr. Reddy’s Confirms Its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market 2.8%
7/29 Dr. Reddy's Laboratories Limited 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 2.8%
9/11 Hazmat situation reported at Dr. Reddy's New York facility [Seeking Alpha] 2.8%
5/20 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A 2.7%
9/9 Form SC 13G DR REDDYS LABORATORIES Filed by: COMMONWEALTH BANK OF AUSTRALIA 2.4%
1/27 Form 6-K DR REDDYS LABORATORIES For: Jan 27 5.3%
4/9 Form SC 13G/A DR REDDYS LABORATORIES Filed by: BlackRock Inc. 4.8%
3/20 Dr. Reddy's launches pyrimethamine tablets in U.S. [Seeking Alpha] 3.9%
3/17 Dr. Reddy's Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market 3.0%
10/23 Dr. Reddy’s Confirms Its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market 2.8%
7/29 Dr. Reddy's Laboratories Limited 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 2.8%
9/11 Hazmat situation reported at Dr. Reddy's New York facility [Seeking Alpha] 2.8%
5/20 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A 2.7%
9/9 Form SC 13G DR REDDYS LABORATORIES Filed by: COMMONWEALTH BANK OF AUSTRALIA 2.4%
TOP News Decliners
3/12
Form 6-K DR REDDYS LABORATORIES For: Mar 12
-6.6%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -6.0%
3/16 Form 6-K DR REDDYS LABORATORIES For: Mar 14 -4.6%
7/29 Dr. Reddy’s Q1 FY20 Financial Results -3.3%
7/29 Q1/2020 6/30/2019 EPS 39.910 ZacksConsensus N/A ActVsEst N/A - N/A -2.9%
7/23 Form 6-K DR REDDYS LABORATORIES For: Jul 23 -2.5%
2/27 Dr. Reddy's Laboratories Announces the First Generic Launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market -2.3%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -1.9%
10/23 Dr. Reddy's is recalling some products used to treat heartburn [CNN] -1.8%
11/22 Dr. Reddy's Laboratories announces launch of Doxercalciferol Injection in the U.S. Market -1.7%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -6.0%
3/16 Form 6-K DR REDDYS LABORATORIES For: Mar 14 -4.6%
7/29 Dr. Reddy’s Q1 FY20 Financial Results -3.3%
7/29 Q1/2020 6/30/2019 EPS 39.910 ZacksConsensus N/A ActVsEst N/A - N/A -2.9%
7/23 Form 6-K DR REDDYS LABORATORIES For: Jul 23 -2.5%
2/27 Dr. Reddy's Laboratories Announces the First Generic Launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market -2.3%
5/17 Q4/2019 3/31/2019 EPS 26.160 ZacksConsensus N/A ActVsEst N/A - N/A -1.9%
10/23 Dr. Reddy's is recalling some products used to treat heartburn [CNN] -1.8%
11/22 Dr. Reddy's Laboratories announces launch of Doxercalciferol Injection in the U.S. Market -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: